SHERRY COFFIELD: Open Payments
NPI 1750552014 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$681 in 35 payments from 14 companies in 2025. Trend: 2023 $1,134 · 2024 $1,248 · 2025 $681
Food & beverage: $681
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $121 |
| Novartis Pharmaceuticals Corporation | 5 | $99 |
| Novo Nordisk Inc | 4 | $83 |
| Exact Sciences Corporation | 4 | $76 |
| Astellas Pharma US Inc | 2 | $59 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| PFIZER INC. | 2 | $29 |
| Lundbeck LLC | 1 | $28 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
Products named: OTEZLA, LEQVIO, Veozah, Ozempic, Rybelsus, Kerendia, Cologuard Collection Kit, VYEPTI.
Industry payments across TN — which companies pay providers there.
